Introduction: Human Immunodeficiency Virus (HIV) infection is a significant cause of paediatric morbidity and mortality especially in Sub-
Introduction
Human Immunodeficiency Virus (HIV) infection is a significant cause of paediatric morbidity and mortality [1] . Almost 90% of all children living with HIV are in Sub-Saharan Africa [1] . In 2011, there were 1.9 million new infections, of which 390,000 were children under 15 years, while there were 2.1 million deaths, of which 250,000 were children, which was 20% fewer than in 2005 [1] . Tanzania Studies have shown an association between HIV infection and development of renal diseases, both in adults and children [5] [6] [7] .
This warrants a close follow up and monitoring of these children before they develop End Stage Renal Disease (ESRD) since renal diseases are indolent and need time for progression [8] . Chronic kidney diseases are not so common in children and the true prevalence is currently unknown, therefore their management is not getting enough attention [9] . Childhood human immunodeficiency virus-associated nephropathy (HIVAN) is defined by the presence of proteinuria associated with mesangial hyperplasia or global-focal segmental glomerulosclerosis and microcytic transformation of renal tubules [7] . Genetic susceptibility has being implicated in enhancing the risk of HIVAN development and it has been shown that black race is the most affected group, commonly presenting with focal segmental glomerulosclerosis [10, 11] . Linkage studies have found genetic susceptibility loci for developing microalbuminuria and HIVAN on chromosomes 3q, 10q and 18q [12] . A polymorphism in the gene for angiotensin II type 1 (AT1) receptor located at chromosome 3q21-25 has been found to be associated with both diabetic and non-diabetic associated nephropathy [13] . Studies have linked the presence of glomerulosclerosis and genetic variants in the MYH9 gene located in the long arm of chromosome 22 [10, 14, 15] .
According to a report from the US Renal Data System, HIVAN had the strongest association with black race in all causes of renal failure among patients who were on maintenance dialysis [13] [14] [15] .
If all HIV infected children are screened for HIVAN and appropriate management instituted, there is a possibility of preventing ESRD in these children [8] . Microalbuminuria defined as urinary albumin excretion between 30 to 300mg/day [16, 17] , is known to be an early marker of HIVAN but it is often undetected because it remains asymptomatic [18, 19] . The prevalence of microalbuminuria varies from region to region and within regions, e.g. in the USA it ranges from 11% [20] to 34% [21] and Africa from 12% [22] to 72% [23] .
In Tanzania Mean (SD) systolic and diastolic blood pressures for all children were in the normal range (92±9 and 59±8 mmHg respectively).
More than three quarters of children 282 (85.5%) had normal nutritional status while only 6 (1.8%) were severely malnourished.
Mean body mass index (BMI) was 16.3±2.5 kg/m² (for children at
Page number not for citation purposes 4 least 60 months old) and mean z-score for weight-for-height (WHZ) for under 60 months was -0.2SD (Table 1) showed that HIV disease category and CD4 count category remained significantly associated with presence of microalbuminuria ( Table 3) .
Discussion
The prevalence of microalbuminuria in HIV infected children in our studywas 28.8%. The factors which were significantly associated with it were low CD4 count and advanced HIV disease. The nutritional status and antiretroviral therapy (ART) duration showed trends towards significant in association with the presence of microalbuminuria. The prevalence findings were similar to other studies conducted in USA [19] [20] [21] , Europe and Africa which found a high prevalence of microalbuminuria in HIV infected children and adults [22] [23] [24] [25] [26] .
However, our findings were different from the study conducted by Uzoma and colleagues in Nigeria who found zero prevalence of microalbuminuria [27] . This difference could probably be explained by the differences in characteristics of the study participants and methodology. Where as we studied subjects who were on HAART, the majority of whom had also advanced HIV disease, in contrast the majority of the subjects in Uzoma's study had non-advanced HIV disease. In our study we used the hemocue albumin analyzer genetic predisposition shown to be associated with the occurrence of kidney diseases but not assessed in this study [10] [11] [12] [13] [14] . We screened the presence of urine albumin in more than one urine sample taken at least one month apart to define microalbuminuria.
This helped to exclude the possibility of transient microalbuminuria which is common in young age.
There were some limitations. We did not limit physical exercise 24 hour before urine collection and this could have had an effect on microalbuminuria especially in lean adolescents. Viral load was not tested in all children and therefore it was not possible to establish the association between viral load and the presence of microalbuminuria. Renal biopsy was not preformed and therefore in
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Conclusion
This urinary screening study has shown that microalbuminuria in HIV infected children is common. HAART use did not influence the presence of microalbuminuria in HIV infected children, but presence of advanced HIV disease and low CD4 count are significant predictors of microalbuminuria.
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